ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CPIX Cumberland Pharmaceutical Inc

1.68
-0.015 (-0.88%)
Last Updated: 10:23:40
Delayed by 15 minutes

Period:

Draw Mode:

Volume 15,496
Bid Price 1.64
Ask Price 1.78
News -
Day High 1.68

Low
1.43

52 Week Range

High
2.3587

Day Low 1.60
Share Name Share Symbol Market Stock Type
Cumberland Pharmaceutical Inc CPIX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.015 -0.88% 1.68 10:23:40
Open Price Low Price High Price Close Price Previous Close
1.68 1.60 1.68 1.695
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
130 15,496 US$ 1.66 US$ 25,721 - 1.43 - 2.3587
Last Trade Type Quantity Price Currency
10:22:49 19 US$ 1.68 USD

Cumberland Pharmaceutical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
23.95M 14.26M - 39.55M -6.28M -0.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cumberland Pharmaceutical News

Date Time Source News Article
4/02/202415:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE..
3/05/202416:10Edgar (US Regulatory)Form 8-K - Current report
3/05/202415:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial..
2/27/202415:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL..
2/09/202416:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
12/28/202316:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/26/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
12/15/202315:14Edgar (US Regulatory)Form DEL AM - Delaying amendment
12/14/202316:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
12/06/202316:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CPIX Message Board. Create One! See More Posts on CPIX Message Board See More Message Board Posts

Historical CPIX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.631.791.571.674,2020.053.07%
1 Month1.731.841.491.695,862-0.05-2.89%
3 Months1.922.23281.491.919,161-0.24-12.50%
6 Months1.972.35871.491.8911,298-0.29-14.72%
1 Year1.702.35871.431.7919,274-0.02-1.18%
3 Years2.757.511.434.93437,677-1.07-38.91%
5 Years5.687.511.434.88272,434-4.00-70.42%

Cumberland Pharmaceutical Description

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ..

Your Recent History

Delayed Upgrade Clock